Navigation Links
GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
Date:2/25/2008

ovided additional support to GeoVax AIDS vaccine development program with a $15 million IPCAVD grant awarded in late 2007.

GeoVax DNA & MVA Genetically Engineered HIV/AIDS vaccines:

-- DNA vaccine "primes" immune responses & MVA vaccine "boosts" immune

responses against the AIDS virus

-- Are both genetically engineered vaccines expressing over 50% of the

AIDS virus components in vaccine recipients and can not cause AIDS

-- Protected 22 of 23 (96%) non-human primates against AIDS for over 31/2

years

-- Are manufactured & tested under GMP/GLP - EMEA (EU) and FDA [USA]

guidelines

-- Satisfactorily completed 2 earlier HIV/AIDS vaccine Phase 1 human

trials

-- Currently have 3 ongoing Phase 1 Human Trials - 1 was initiated in

2006, 2 in summer 2007

-- Have been demonstrated safe to date in human trials

-- Demonstrate positive anti-HIV immune responses in majority of human

vaccine recipients

-- Are planned for mid 2008 Phase 2 trials based on success in previous

HVTN conducted trials

Safe Harbor Statement: All statements in this news release, not statements of historical fact, are forward-looking statements. These statements are based on expectations and assumptions on the date of this press release and are subject to numerous risks and uncertainties which could cause actual results to differ materially from those described in forward-looking statements. Risks and uncertainties include, but are not limited to, whether: GeoVax can develop and manufacture these vaccines with the desired characteristics in a timely manner, GeoVax's vaccines will be safe for human use, GeoVax's vaccines will effectively prevent AIDS in humans, vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete vaccine development, there is development of competitive products that may be more
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
2. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
3. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
4. GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update
5. Excellent Results Received from GeoVaxs Full-Dose HIV/AIDS Vaccine Trial
6. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
7. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
8. New Patent Awarded for Antigen-Sparing Vaccines that Elicit Robust Immunity
9. Hawaii Biotech Receives Allowance to Perform West Nile Vaccine Clinical Trials
10. Celldex Therapeutics Receives Fast-Track Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma
11. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... April 20, 2015 Pharmaceutical Research and Manufacturers ... billion last year in the research and development (R&D) ... the majority of all biopharmaceutical R&D spending – both ... States . The new R&D numbers, the result ... highlighted in the newly released PhRMA 2015 ...
(Date:4/20/2015)...  Purdue Pharma, a leading specialty pharmaceutical company, ... joined the company as Senior Vice President of ... for all of Purdue,s efforts to acquire or ... benefit from our patient-focused commercial capabilities. ... President & CEO Mark Timney . "Alan ...
(Date:4/20/2015)... LINCOLNSHIRE, Ill. , April 20, 2015  U.S. pharmacy ... are expected to drift into the low double-digits by 2016, ... global talent, retirement and health solutions business of Aon ... plan design changes are projected to be 9.5 percent in ... 2016. Aon Hewitt predicts a similar rate of ...
Breaking Medicine Technology:PhRMA Member Companies Invested $51.2 Billion in R&D in 2014 2PhRMA Member Companies Invested $51.2 Billion in R&D in 2014 3Purdue Pharma Names J. Alan Butcher Senior Vice President of Licensing & Business Development 2Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 2Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 4
... Corp. (NASDAQ: KOOL ), a leading supplier of ... cells, said today that Mahendra Rao, M.D., Ph.D. has resigned ... Rao has been appointed to a position with the National ... a director of the Company, pursuant to NIH and federal ...
... 1, 2011 Merrimack Pharmaceuticals, Inc. announced today ... has granted MM-398 orphan drug status for the ... stable nanotherapeutic encapsulation of the marketed chemotherapy drug ... development and commercialization in Taiwan under the designation ...
Cached Medicine Technology:ThermoGenesis Names Former Applied Imaging CEO Robin Stracey to Board of Directors, Replacing Dr. Mahendra Rao 2ThermoGenesis Names Former Applied Imaging CEO Robin Stracey to Board of Directors, Replacing Dr. Mahendra Rao 3FDA Grants Orphan Drug Status to Merrimack Pharmaceuticals' MM-398, a Nanotherapeutic Encapsulation of Irinotecan, for the Treatment of Pancreatic Cancer 2
(Date:4/21/2015)... CA (PRWEB) April 21, 2015 CALNOC, ... Linda Burnes Bolton, DrPH, RN, FAAN, will keynote their ... - in Long Beach, CA on October 26, 2015. ... of the American Organization of Nurse Executives (AONE) and ... past president of the American Academy of Nursing and ...
(Date:4/21/2015)... The Science Museum of Virginia welcomes theoretical nuclear physicist, Dr. ... Science program. On Wednesday, April 29, Dr. Briceno will present ... subatomic world of quantum mechanics to astronomical scales where stars ... community to grab lunch and take a bite out of ... the nucleus and dissect the complex world of quarks and ...
(Date:4/21/2015)... 2015 Renewable energy, sustainable living, the ... the Earth Day topics USM Studios ’ programming ... debate the affect of climate change on the planet, ... matter touching on the environmental concerns affecting the nation ... into sustainable lifestyles, clean air options, and much more ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 On Saturday, ... and the rest of his team from Georgia ... Walk to End Lupus Now, being held in Piedmont ... Atlanta Walk proved to be the largest LFA-sponsored walk ... an effort to raise funds and awareness for lupus, ...
(Date:4/21/2015)... Invictus Medical has secured the ... for a second innovative technology aimed at making ... newborn infants’ cognitive development. , “This technology addresses ... have identified through extensive interviews and input from ... Invictus Medical’s Chief Technology Officer. “We believe this ...
Breaking Medicine News(10 mins):Health News:Nationally Recognized Nurse Leader Linda Burnes Bolton to Present Keynote Address at CALNOC Conference 2Health News:Quarks and Forks at the Science Museum of Virginia 2Health News:USM Studios’ Programming Focuses on the Environment 2Health News:9th Annual Walk to End Lupus Now 2Health News:9th Annual Walk to End Lupus Now 3Health News:Invictus Medical Secures Rights to Second Promising New NICU Technology 2
... Salamon HealthDay Reporter , TUESDAY, Aug. 2 (HealthDay ... but there may be a way to shorten its misery: ... in certain formulations may cut the length of colds by ... the University of Helsinki in Finland, reviewed 13 placebo-controlled trials ...
... (GSA) the nation,s largest interdisciplinary organization devoted to ... of the College of St. Scholastica as the 2011 ... Gerontology Outstanding Mentorship Award. This distinguished honor is ... commitment and dedication to mentoring minority researchers in the ...
... the nation,s largest interdisciplinary organization devoted to the field ... Boston University as the 2011 recipient of the Excellence ... honor is given annually to acknowledge outstanding contributions in ... in any or all of the areas of teaching ...
... (GSA) the nation,s largest interdisciplinary organization devoted to ... Dixit, DVM, PhD, of the Pennington Biomedical Research Center ... Investigator Award. The distinguished honor is given for ... biological research. It was established in 1986 to honor ...
... used to determine whether a lung cancer patient is ... in the August issue of the Journal of ... International Association for the Study of Lung Cancer (IASLC). ... found to respond well to crizotinib, an ALK inhibitor ...
... , TUESDAY, Aug. 2 (HealthDay News) -- Americans used to ... the case, according to a new study that gives high-income ... in particular, and obesity are to blame, said the U.S. ... expectancy in coming years and help to reduce health care ...
Cached Medicine News:Health News:Larger Dose of Zinc Lozenges May Shorten Colds 2Health News:Mehrotra to receive GSA's 2011 Minority Mentorship Award 2Health News:Jette to receive GSA's 2011 Excellence in Rehabilitation of Aging Persons Award 2Health News:Dixit to receive GSA's 2011 Nathan Shock New Investigator Award 2Health News:Americans No Longer Outliving Europeans: Study 2
Turnstile casting stand for easy and safe casting. The compact system sets up quickly and stores conveniently, and the non-stick coating prevents fiberglass or plaster from adhering to surface....
Bone cement with Gentamicin 2.5%....
... Techno-Aide provides the highest level of ... quality lead protective eyewear. Consistent ... tolerance allowed. Mfg supervised by Licensed ... lens meet or exceed standards for ...
... Comfort fit large designer ... adjustable strap bridge providing a ... on the nose. The head ... for custom fit. The acrylic ...
Medicine Products: